NL-OMON53842
Completed
Not Applicable
Exploring biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer*s disease, schizophrenia, and major depression: replication and generalisability of the Psychiatric Ratings using Intermediate Stratified Markers (PRISM)1 study - PRISM2
Gregorio Marañón Hospital0 sites90 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer's disease and Major Depressive Disorder
- Sponsor
- Gregorio Marañón Hospital
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria (MDD, SZ and AD populations)
- •\- Provision of signed and dated informed consent form (ICF) from patient prior
- •to any study\-specific procedures being performed.
- •\- The patient should have a reliable study partner with whom he/she cohabits or
- •has regular contact with, who gives consent to participate in the study and
- •provide study data (limited to the Neuropsychiatric Inventory for AD patients
- •and the WHO Disability Asessment Schedule (WHODAS) for AD, SZ and MDD patients).
- •\- Not socially withdrawn due to external circumstances (e.g. lack of access to
- •transport, rural location) or comorbid medical disorder or disability (e.g.,
- •hearing loss, lack of mobility, facial disfigurement).
Exclusion Criteria
- •Exclusion criteria (MDD, SZ and AD populations)
- •Patients cannot enter the study if any of the following exclusion criteria are
- •\- Significant neurological disease affecting the CNS, other than AD, SZ, or MDD
- •(e.g. other dementias, serious infection of the brain, Parkinson\*s disease,
- •epilepsy) as documented in the patient\*s medical file which in the judgement of
- •the investigator may affect the patient's ability to complete the study
- •assessments.
- •\- Any other current psychiatric diagnosis, including personality disorders,
- •requiring intervention other than AD, SZ, and MDD according to medical history
- •that in the judgement of the investigator may affect the patient's ability to
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
biological and chronological age gap studyCTRI/2021/03/032344Krishna institute of medical sciences
Active, not recruiting
Phase 2
Genetic, immune and treatment-related differences in cancers of the mouth and throat in India.Health Condition 1: C32- Malignant neoplasm of larynxHealth Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2020/10/028482ational Institutes of Health USA
Not yet recruiting
Phase 4
Effect of targeted fluid therapy on ischemic complicationsHealth Condition 1: G968- Other specified disorders of central nervous systemCTRI/2024/04/065167Rajeeb Kumar Mishra
Not yet recruiting
Not Applicable
Biomarker based intervention strategies to combat adverse effects of shift workslaap, vermoeidheid, wellbevindenmetabolic healthsleep1000301810040991NL-OMON53661Erasmus MC, Universitair Medisch Centrum Rotterdam75
Completed
Not Applicable
Providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer*s disease and schizophrenia.NL-OMON49237niversitair Medisch Centrum Utrecht138